Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. Read more about Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.
Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. Read more about Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. Read more about Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. Read more about Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.
Generalizability of established prostate cancer risk variants in men of African ancestry. Read more about Generalizability of established prostate cancer risk variants in men of African ancestry.
Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. Read more about Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. Read more about Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.
PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia. Read more about PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.
Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer. Read more about Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts. Read more about Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts.
